机译:Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?
Univ Messina, Nucl Med Unit, Dept Biomed Sci & Morphol & Funct Images, I-98125 Messina, Italy;
Non-radioiodine-avid differentiated thyroid cancer; Peptide radionuclide receptor therapy; Radioiodine-131; Lutetium-177;